Advanced

HLA Heterozygosity in Insulin‐Dependent Diabetes is Most Frequent at the DQ Locus

MICHELSEN, B. ; WASSMUTH, R. ; LUDVIGSSON, J. ; LERNMARK LU ; NEPOM, G. T. and FISHER, L. (1990) In Scandinavian Journal of Immunology 31(4). p.405-413
Abstract

Restriction fragment length polymorphism using an HLA‐DQ β‐chain genomic probe showed that 63 children with insulin‐dependent (type 1) diabetes mellitus (IDDM) were all (100%) positive for the BamH1 fragments 12 kb and/or 4 kb compared to 98% (62/63) for HLA‐DR3 and/or 4 and 75% (47/63) for HLA‐B8 and/or 15. The 36 (56%) DR3‐positive children were all 4‐kb‐positive; however, a total of 44 (70%) children were 4‐kb‐positive (P < 0.02). The 55 (87%) DR4‐positive children were all 12‐kb‐positive, but a total of 56 (89%) were 12‐kb‐positive (NS), The heterozygosity at the HLA region increased from 11/63 (18%) for HLA‐B8/15 to 29/63 (46%) for HLA‐DR3/4 (P < 0,0004) and to 37/63 (59%) for the HLA‐DQ 4 kb/12 kb fragments (P < 0.02).... (More)

Restriction fragment length polymorphism using an HLA‐DQ β‐chain genomic probe showed that 63 children with insulin‐dependent (type 1) diabetes mellitus (IDDM) were all (100%) positive for the BamH1 fragments 12 kb and/or 4 kb compared to 98% (62/63) for HLA‐DR3 and/or 4 and 75% (47/63) for HLA‐B8 and/or 15. The 36 (56%) DR3‐positive children were all 4‐kb‐positive; however, a total of 44 (70%) children were 4‐kb‐positive (P < 0.02). The 55 (87%) DR4‐positive children were all 12‐kb‐positive, but a total of 56 (89%) were 12‐kb‐positive (NS), The heterozygosity at the HLA region increased from 11/63 (18%) for HLA‐B8/15 to 29/63 (46%) for HLA‐DR3/4 (P < 0,0004) and to 37/63 (59%) for the HLA‐DQ 4 kb/12 kb fragments (P < 0.02). The test of an equal probability ofa positive result under the adjacent pair of tests indicates that the increased risk of developing IDDM in association with HLA‐DQ is to a great extent due to heterozygosity at this locus. There were no differences between the 4 kb/12 kb and the DR3/4‐positive IDDM children with respect to fasting or meal‐stimulated C peptide, insulin requirement, or levels of insulin antibodies formed during the first 12 months of insulin therapy. Our results support the hypothesis that HLA‐DQ is closely associated with an increased risk of childhood IDDM, and when typed for at this locus parameters of the clinical course were homogeneous, suggesting that factors other than HLA‐DQ may determine previously observed differences between IDDM children in clinical or functional parameters.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
publishing date
type
Contribution to journal
publication status
published
in
Scandinavian Journal of Immunology
volume
31
issue
4
pages
9 pages
publisher
Wiley-Blackwell
external identifiers
  • pmid:2333466
  • scopus:0025304183
ISSN
0300-9475
DOI
10.1111/j.1365-3083.1990.tb02786.x
language
English
LU publication?
no
id
2e3d0a2e-3b5e-4eeb-8c77-51c60d9d8016
date added to LUP
2019-09-11 09:43:59
date last changed
2020-04-16 20:58:47
@article{2e3d0a2e-3b5e-4eeb-8c77-51c60d9d8016,
  abstract     = {<p>Restriction fragment length polymorphism using an HLA‐DQ β‐chain genomic probe showed that 63 children with insulin‐dependent (type 1) diabetes mellitus (IDDM) were all (100%) positive for the BamH1 fragments 12 kb and/or 4 kb compared to 98% (62/63) for HLA‐DR3 and/or 4 and 75% (47/63) for HLA‐B8 and/or 15. The 36 (56%) DR3‐positive children were all 4‐kb‐positive; however, a total of 44 (70%) children were 4‐kb‐positive (P &lt; 0.02). The 55 (87%) DR4‐positive children were all 12‐kb‐positive, but a total of 56 (89%) were 12‐kb‐positive (NS), The heterozygosity at the HLA region increased from 11/63 (18%) for HLA‐B8/15 to 29/63 (46%) for HLA‐DR3/4 (P &lt; 0,0004) and to 37/63 (59%) for the HLA‐DQ 4 kb/12 kb fragments (P &lt; 0.02). The test of an equal probability ofa positive result under the adjacent pair of tests indicates that the increased risk of developing IDDM in association with HLA‐DQ is to a great extent due to heterozygosity at this locus. There were no differences between the 4 kb/12 kb and the DR3/4‐positive IDDM children with respect to fasting or meal‐stimulated C peptide, insulin requirement, or levels of insulin antibodies formed during the first 12 months of insulin therapy. Our results support the hypothesis that HLA‐DQ is closely associated with an increased risk of childhood IDDM, and when typed for at this locus parameters of the clinical course were homogeneous, suggesting that factors other than HLA‐DQ may determine previously observed differences between IDDM children in clinical or functional parameters.</p>},
  author       = {MICHELSEN, B. and WASSMUTH, R. and LUDVIGSSON, J. and LERNMARK and NEPOM, G. T. and FISHER, L.},
  issn         = {0300-9475},
  language     = {eng},
  month        = {01},
  number       = {4},
  pages        = {405--413},
  publisher    = {Wiley-Blackwell},
  series       = {Scandinavian Journal of Immunology},
  title        = {HLA Heterozygosity in Insulin‐Dependent Diabetes is Most Frequent at the DQ Locus},
  url          = {http://dx.doi.org/10.1111/j.1365-3083.1990.tb02786.x},
  doi          = {10.1111/j.1365-3083.1990.tb02786.x},
  volume       = {31},
  year         = {1990},
}